Carregant...
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
Tofacitinib is an oral, Janus kinase (JAK) molecule, which selectively inhibits Janus-associated tyrosine kinases JAK1 and JAK3. It has already shown efficacy in the treatment of rheumatoid arthritis and the prevention of organ allograft rejection in kidney transplantation. Two separate phase III pl...
Guardat en:
| Publicat a: | Frontline Gastroenterol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873536/ https://ncbi.nlm.nih.gov/pubmed/33613945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2020-101502 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|